Hepatic expression patterns of inflammatory and immune response genes associated with obesity and nash in morbidly obese patients

PLoS ONE

Volumn 5, Issue 10, 2010, Pages

  Bertola, Adeline ^a,b   Bonnafous, Stéphanie ^a,b,c   Anty, Rodolphe ^a,b,c   Patouraux, Stéphanie ^c   Saint Paul, Marie Christine ^a,b,c   Iannelli, Antonio ^c   Gugenheim, Jean ^a,b,c   Barr, Jonathan ^d   Mato, José M ^e   Le Marchand Brustel, Yannick ^a,b,c   Tran, Albert ^a,b,c   Gual, Philippe ^a,b,c  

^a INSERM   (France)

^b UNIVERSITÉ CÔTE D'AZUR   (France)

^c UNIVERSITY HOSPITAL OF NICE   (France)

^d OWL Genomics   (Spain)

^e INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CHEMOKINE; CHEMOKINE RECEPTOR; CYTOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; JANUS KINASE; LIPOPOLYSACCHARIDE; LYMPHOTOXIN; MATRIX METALLOPROTEINASE; MONOCYTE CHEMOTACTIC PROTEIN 1; NEUROPILIN; PALMITIC ACID; PLEXIN; SEMAPHORIN; STAT PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME ACTIVATION; FATTY LIVER; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC CODE; GENETIC REGULATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE GENE; INTRAABDOMINAL FAT; LEUKOCYTE; MALE; MORBID OBESITY; NONALCOHOLIC FATTY LIVER; PHENOTYPE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TH1 CELL; UPREGULATION; CASE CONTROL STUDY; GENE EXPRESSION PROFILING; GENETICS; IMMUNOLOGY; INFLAMMATION; LIVER; METABOLISM;

ADULT; CASE-CONTROL STUDIES; FATTY LIVER; FEMALE; GENE EXPRESSION PROFILING; HUMANS; INFLAMMATION; LIVER; MALE; OBESITY, MORBID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 78149450628     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0013577     Document Type: Article

References (56)

1. McCullough AJ (2006) Pathophysiology of nonalcoholic steatohepatitis. J Clin Gastroenterol 40 Suppl 1: S17-29.
2. Neuschwander-Tetri BA, Caldwell SH (2003) Nonalcoholic steatohepatitis: summary of an AASLD single topic conference. Hepatology 37: 1202-1219.
3. Valenti L, Ludovica Fracanzani A, Fargion S (2009) The immunopathogenesis of alcoholic and nonalcoholic steatohepatitis: two triggers for one disease? Semin Immunopathol.
4. Xu H, Barnes GT, Yang Q, Tan G, Yang D, et al. (2003) Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112: 1821-1830.
5. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, et al. (2003) Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112: 1796-1808.
6. Bertola A, Deveaux V, Bonnafous S, Rousseau D, Anty R, et al. (2009) Elevated expression of osteopontin may be related to adipose tissue macrophage accumulation and liver steatosis in morbid obesity. Diabetes 58: 125-133.
7. Maher JJ, Leon P, Ryan, C J (2008) Beyond insulin resistance: Innate immunity in nonalcoholic steatohepatitis. Hepatology 48: 670-678.
8. Sanyal AJ, Campbell-Sargent C, Mirshahi F, Rizzo WB, Contos MJ, et al. (2001) Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology 120: 1183-1192.
9. Donnelly KL, Smith CI, Schwarzenberg SJ, Jessurun J, Boldt MD, et al. (2005) Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest 115: 1343-1351.
10. Anty R, Bekri S, Luciani N, Saint-Paul MC, Dahman M, et al. (2006) The inflammatory C-reactive protein is increased in both liver and adipose tissue in severely obese patients independently from metabolic syndrome, Type 2 diabetes, and NASH. Am J Gastroenterol 101: 1824-1833.
11. Bekri S, Gual P, Anty R, Luciani N, Dahman M, et al. (2006) Increased adipose tissue expression of hepcidin in severe obesity is independent from diabetes and NASH. Gastroenterology 131: 788-796.
12. Anty R, Dahman M, Iannelli A, Gual P, Staccini-Myx A, et al. (2008) Bariatric surgery can correct iron depletion in morbidly obese women: a link with chronic inflammation. Obes Surg 18: 709-714.
13. Tilg H, Moschen AR, Kaser A (2009) Obesity and the microbiota. Gastroenterology 136: 1476-1483.
14. Seki E, Brenner DA (2008) Toll-like receptors and adaptor molecules in liver disease: update. Hepatology 48: 322-335.
15. Xu CF, Yu CH, Li YM, Xu L, Du J, et al. (2007) Association of the frequency of peripheral natural killer T cells with nonalcoholic fatty liver disease. World J Gastroenterol 13: 4504-4508.
16. Albano E, Mottaran E, Vidali M, Reale E, Saksena S, et al. (2005) Immune response towards lipid peroxidation products as a predictor of progression of non-alcoholic fatty liver disease to advanced fibrosis. Gut 54: 987-993.
17. Crespo J, Cayon A, Fernandez-Gil P, Hernandez-Guerra M, Mayorga M, et al. (2001) Gene expression of tumor necrosis factor alpha and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients. Hepatology 34: 1158-1163.
18. Wieckowska A, Papouchado BG, Li Z, Lopez R, Zein NN, et al. (2008) Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis. Am J Gastroenterol 103: 1372-1379.
19. Haukeland JW, Damas JK, Konopski Z, Loberg EM, Haaland T, et al. (2006) Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2. J Hepatol 44: 1167-1174.
20. Cayon A, Crespo J, Guerra AR, Pons-Romero F (2008) [Gene expression in obese patients with non-alcoholic steatohepatitis]. Rev Esp Enferm Dig 100: 212-218.
21. Lee JY, Sohn KH, Rhee SH, Hwang D (2001) Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through Toll-like receptor 4. J Biol Chem 276: 16683-16689.
22. Yokoyama Y, Nimura Y, Nagino M, Bland KI, Chaudry IH (2005) Current understanding of gender dimorphism in hepatic pathophysiology. J Surg Res 128: 147-156.
23. Waxman DJ, Holloway MG (2009) Sex differences in the expression of hepatic drug metabolizing enzymes. Mol Pharmacol 76: 215-228.
24. Suzuki A, Abdelmalek MF (2009) Nonalcoholic fatty liver disease in women. Womens Health (Lond Engl) 5: 191-203.
25. Cortez-Pinto H, de Moura MC, Day CP (2006) Non-alcoholic steatohepatitis: from cell biology to clinical practice. J Hepatol 44: 197-208.
26. Brunt EM (2001) Nonalcoholic steatohepatitis: definition and pathology. Semin Liver Dis 21: 3-16.
27. Bigorgne AE, Bouchet-Delbos L, Naveau S, Dagher I, Prevot S, et al. (2008) Obesity-induced lymphocyte hyperresponsiveness to chemokines: a new mechanism of Fatty liver inflammation in obese mice. Gastroenterology 134: 1459-1469.
28. Joshi-Barve S, Barve SS, Amancherla K, Gobejishvili L, Hill D, et al. (2007) Palmitic acid induces production of proinflammatory cytokine interleukin-8 from hepatocytes. Hepatology 46: 823-830.
29. Ito S, Yukawa T, Uetake S, Yamauchi M (2007) Serum intercellular adhesion molecule-1 in patients with nonalcoholic steatohepatitis: comparison with alcoholic hepatitis. Alcohol Clin Exp Res 31: S83-87.
30. Diao H, Kon S, Iwabuchi K, Kimura C, Morimoto J, et al. (2004) Osteopontin as a mediator of NKT cell function in T cell-mediated liver diseases. Immunity 21: 539-550.
31. Ashkar S, Weber GF, Panoutsakopoulou V, Sanchirico ME, Jansson M, et al. (2000) Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity. Science 287: 860-864.
32. Mimura S, Mochida S, Inao M, Matsui A, Nagoshi S, et al. (2004) Massive liver necrosis after provocation of imbalance between Th1 and Th2 immune reactions in osteopontin transgenic mice. J Gastroenterol 39: 867-872.
33. Guebre-Xabier M, Yang S, Lin HZ, Schwenk R, Krzych U, et al. (2000) Altered hepatic lymphocyte subpopulations in obesity-related murine fatty livers: potential mechanism for sensitization to liver damage. Hepatology 31: 633-640.
34. Li Z, Lin H, Yang S, Diehl AM (2002) Murine leptin deficiency alters Kupffer cell production of cytokines that regulate the innate immune system. Gastroenterology 123: 1304-1310.
35. Loffreda S, Yang SQ, Lin HZ, Karp CL, Brengman ML, et al. (1998) Leptin regulates proinflammatory immune responses. Faseb J 12: 57-65.
36. Tilg H, Diehl AM (2000) Cytokines in alcoholic and nonalcoholic steatohepatitis. N Engl J Med 343: 1467-1476.
37. Li Z, Soloski MJ, Diehl AM (2005) Dietary factors alter hepatic innate immune system in mice with nonalcoholic fatty liver disease. Hepatology 42: 880-885.
38. Elinav E, Pappo O, Sklair-Levy M, Margalit M, Shibolet O, et al. (2006) Amelioration of non-alcoholic steatohepatitis and glucose intolerance in ob/ob mice by oral immune regulation towards liver-extracted proteins is associated with elevated intrahepatic NKT lymphocytes and serum IL-10 levels. J Pathol 208: 74-81.
39. Pacifico L, Di Renzo L, Anania C, Osborn JF, Ippoliti F, et al. (2006) Increased T-helper interferon-gamma-secreting cells in obese children. Eur J Endocrinol 154: 691-697.
40. Suzuki K, Kumanogoh A, Kikutani H (2008) Semaphorins and their receptors in immune cell interactions. Nat Immunol 9: 17-23.
41. Mizui M, Kumanogoh A, Kikutani H (2009) Immune semaphorins: novel features of neural guidance molecules. J Clin Immunol 29: 1-11.
42. Cancello R, Tordjman J, Poitou C, Guilhem G, Bouillot JL, et al. (2006) Increased infiltration of macrophages in omental adipose tissue is associated with marked hepatic lesions in morbid human obesity. Diabetes 55: 1554-1561.
43. Tordjman J, Poitou C, Hugol D, Bouillot JL, Basdevant A, et al. (2009) Association between omental adipose tissue macrophages and liver histopathology in morbid obesity: influence of glycemic status. J Hepatol 51: 354-362.
44. Baranova A, Schlauch K, Elariny H, Jarrar M, Bennett C, et al. (2007) Gene expression patterns in hepatic tissue and visceral adipose tissue of patients with non-alcoholic fatty liver disease. Obes Surg 17: 1111-1118.
45. Estep JM, Baranova A, Hossain N, Elariny H, Ankrah K, et al. (2009) Expression of cytokine signaling genes in morbidly obese patients with nonalcoholic steatohepatitis and hepatic fibrosis. Obes Surg 19: 617-624.
46. Poggi M, Bastelica D, Gual P, Iglesias MA, Gremeaux T, et al. (2007) C3H/HeJ mice carrying a toll-like receptor 4 mutation are protected against the development of insulin resistance in white adipose tissue in response to a highfat diet. Diabetologia 50: 1267-1276.
47. Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, et al. (2007) Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56: 1761-1772.
48. Szabo G, Velayudham A, Romics L, Jr., Mandrekar P (2005) Modulation of non-alcoholic steatohepatitis by pattern recognition receptors in mice: the role of toll-like receptors 2 and 4. Alcohol Clin Exp Res 29: 140S-145S.
49. Rivera CA, Adegboyega P, van Rooijen N, Tagalicud A, Allman M, et al. (2007) Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis. J Hepatol 47: 571-579.
50. Yang SQ, Lin HZ, Lane MD, Clemens M, Diehl AM (1997) Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis. Proc Natl Acad Sci U S A 94: 2557-2562.
51. Li Z, Yang S, Lin H, Huang J, Watkins PA, et al. (2003) Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease. Hepatology 37: 343-350.
52. Solga SF, Diehl AM (2003) Non-alcoholic fatty liver disease: lumen-liver interactions and possible role for probiotics. J Hepatol 38: 681-687.
53. Lanthier N, Molendi-Coste O, Horsmans Y, van Rooijen N, Cani PD, et al. (2009) Kupffer cell activation is a causal factor for hepatic insulin resistance. Am J Physiol Gastrointest Liver Physiol.
54. Huang W, Metlakunta A, Dedousis N, Zhang P, Sipula I, et al. (2010) Depletion of liver Kupffer cells prevents the development of diet-induced hepatic steatosis and insulin resistance. Diabetes 59: 347-357.
55. Wallace TM, Levy JC, Matthews DR (2004) Use and abuse of HOMA modeling. Diabetes Care 27: 1487-1495.
56. Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, et al. (2005) Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41: 1313-1321.